ArticlePharmaceutics2025

Selection of Solubility Enhancement Technologies for S-892216, a Novel COVID-19 Drug Candidate.

Ryo Ohashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.